BONNIE L. BASSLER, PH.D. - Corporate Board Profile

REGENERON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2017-04-25	Dr. Bassler is currently the Chair of the Department of Molecular Biology and the Squibb Professor in Molecular Biology at Princeton University, and a Howard Hughes Medical Institute Investigator. ... Dr. Bassler was elected as a member of the board and the Corporate Governance and Compliance Committee and the Technology Committee effective September 9, 2016. ... Compensation of Directors: Bonnie L. Bassler, Ph.D. 2,456,527.
2018-04-23	BONNIE L. BASSLER, Ph.D. Director since: 2016 Age: 55 Independent Scientific Society Memberships The National Academy of Sciences The American Academy of Arts and Sciences Dr. Bassler is currently the Chair of the Department of Molecular Biology and the Squibb Professor in Molecular Biology at Princeton University, and a Howard Hughes Medical Institute Investigator. Dr. Bassler has previously served as the President of the American Society for Microbiology, as well as on the boards for the American Association for the Advancement of Science, the National Science Foundation, and the American Academy of Microbiology. She has been elected to the National Academy of Sciences, the American Academy of Arts and Sciences, the Royal Society of London, and the American Philosophical Society, and has received many scientific honors, including a MacArthur Foundation Fellowship, the Lounsbery Award, and the Shaw Prize for Life Science and Medicine. Dr. Bassler received her B.Sc. from the University of California, Davis, and her Ph.D. in Biochemistry from Johns Hopkins University. She served as a Postdoctoral Fellow and Research Scientist at the Agouron Institute in La Jolla, California, before becoming a faculty member at Princeton University. Dr. Bassler served as a director of Sanofi from November 2014 to July 2016. Board and Committee Membership: Board of Directors, Corporate Governance and Compliance Committee, Technology Committee. Compensation of Directors table shows $75,000 fees earned in cash and $383,656 option awards totaling $458,656.
2019-04-26	Dr. Bassler is currently the Chair of the Department of Molecular Biology and the Squibb Professor in Molecular Biology at Princeton University, and a Howard Hughes Medical Institute Investigator. ... Board and Committee Membership — 2018 Attendance: Board of Directors 6/6, Corporate Governance and Compliance Committee 5/5, Technology Committee 3/3. ... Director Compensation Table: Bonnie L. Bassler, Ph.D. Fees earned or paid in cash ($) 75,000, Option awards ($) 1,143,907, Total ($) 1,218,907.
2021-04-23	Dr. Bassler is currently the Chair of the Department of Molecular Biology and the Squibb Professor in Molecular Biology at Princeton University, and a Howard Hughes Medical Institute Investigator. Dr. Bassler has previously served as the President of the American Society for Microbiology, as well as on the boards for the American Association for the Advancement of Science, the National Science Foundation, and the American Academy of Microbiology. She has been elected to the National Academy of Sciences, the American Academy of Arts and Sciences, the Royal Society of London, and the American Philosophical Society, and has received many scientific honors, including a MacArthur Foundation Fellowship, the Lounsbery Award, and the Shaw Prize for Life Science and Medicine. Dr. Bassler received her B.Sc. from the University of California, Davis, and her Ph.D. in Biochemistry from Johns Hopkins University. She served as a Postdoctoral Fellow and Research Scientist at the Agouron Institute in La Jolla, California, before becoming a faculty member at Princeton University. Dr. Bassler served as a director of Sanofi from November 2014 to July 2016 and currently serves on the board of directors of Kaleido Biosciences, Inc., Cidara Therapeutics, Inc., and Royalty Pharma plc. Dr. Bassler's extensive research experience and her scientific and academic career and accomplishments, as well as her experience as a corporate director, led the board to conclude that Dr. Bassler should serve as a director. Board and Committee Membership—2020 Attendance: Board of Directors: 11/11 Corporate Governance and Compliance Committee: 5/5 Technology Committee: 3/3 Prior Voting Results—2019: For: 75.4% Against: 24.6% Regeneron Securities Beneficially Owned as of April 13, 2021: Common Stock: 0 Options: 29,821 RSUs: 750
2022-04-21	Bonnie L. Bassler, Ph.D. Director since: 2016 Age: 59 Independent Board and Committee Membership–2021 Attendance Board of Directors: 9/9 Corporate Governance and Compliance Committee: 5/5 Technology Committee: 2/2 Director Compensation Table: Bonnie L. Bassler, Ph.D. Total: 710,094
2024-04-25	Bonnie L. Bassler, Ph.D. - Director since 2016, Age 61. Board and Committee Membership—2023 Attendance: Corporate Governance and Compliance Committee. Compensation: $709,987.